Scientists uncover a hidden liver pathway that destroys LDL receptors, opening a promising new front in the fight against ...

A single infusion of an experimental gene-editing therapy reduced LDL cholesterol in patients with familial ...

Heart disease is still the leading cause of death worldwide, and high cholesterol is a major driver of that problem.

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, ...

Researchers say newly identified cholesterol control pathway is completely separate from anything targeted by existing drugs.

An alternative drug to statins could help control potentially deadly cholesterol, say scientists. Researchers have discovered ...

National Institute of Health (NIH) scientists have made a significant breakthrough in understanding how "bad" cholesterol, known as low-density lipoprotein-cholesterol or LDL-C, builds up in the body.

Enlicitide is the first oral PCSK9 inhibitor to demonstrate statistically significant and clinically meaningful reductions in LDL-C compared to placebo in Phase 3 trials RAHWAY, N.J.--(BUSINESS WIRE)- ...

A potential alternative to statins could help manage dangerously high cholesterol levels, according to scientists.

Cardiovascular researchers have spent years zeroing in on apolipoprotein B (ApoB) as a sharper predictor of heart disease ...